SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-16-042678
Filing Date
2016-11-28
Accepted
2016-11-28 17:05:35
Documents
4
Period of Report
2017-01-06

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A dffn20161125_pre14a.htm PRE 14A 632661
2 a2.jpg GRAPHIC 108271
3 a1.jpg GRAPHIC 240949
4 ex99-1img001.jpg GRAPHIC 4079
  Complete submission text file 0001437749-16-042678.txt   1120596
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37942 | Film No.: 162020531
SIC: 2834 Pharmaceutical Preparations